Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2023-10-01–present
Don DeGolyer
Board Member
Emergent BioSolutions Inc. (EBS)Equibles does not estimate personal net worth.
About Don DeGolyer
Don DeGolyer is recorded as Board Member at Emergent BioSolutions Inc. (EBS) since October 1, 2023. Emergent BioSolutions Inc. reported in an 8-K filed October 2, 2023 that Don DeGolyer was appointed Board of Directors, effective October 1, 2023. Emergent BioSolutions Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Emergent BioSolutions Inc. includes Daniel J. Abdun-Nabi (CEO, COO and Board Member), Joseph C. Papa (CEO and Board Member), Joseph Papa (CEO and Board Member) and 7 others.
“Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with initial terms expiring at Emergent's 2024 annual meeting of stockholders.”
Affiliation history
-
Current
2023-10-01–present
Company network
Leadership on record at Emergent BioSolutions Inc.
- Daniel J. Abdun-Nabi CEO, COO, Board Member
- Joseph C. Papa CEO, Board Member
- Joseph Papa CEO, Board Member
- Robert G. Kramer, Sr. CEO, Board Member
- Zsolt Harsanyi Chairman, Board Member
- Frank Vargo CFO
- Richard S. Lindahl CFO
- Robert G. Kramer CFO
- Adam Havey COO
- Jessica Perl General Counsel